You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aubagio®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting Trial in Bordeaux (Clinical assessment, Ecological evaluation, Neuropsychological

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Clinical assessment
  • +4 more
  • Bordeaux, France
    CHU de Bordeaux - Service de neurologie
Feb 2, 2022

Teriflunomide on Cognitive and Vocational Outcomes in Multiple

Completed
Has Results
  • Multiple Sclerosis
    • Buffalo, New York
      Buffalo General Hospital, D3
    Aug 31, 2021

    Mechanistic Studies of Teriflunomide in RRMS

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Ann Arbor, Michigan
      University of Michigan
    Jul 27, 2022

    Relationship Between Oral DMT Burden and Adherence in MS

    Enrolling by invitation
    • Multiple Sclerosis
    • Adherence, Medication
    • Melbourne, Victoria, Australia
      Monash University
    Aug 28, 2022

    Disease Activity in Patients Treated With Teriflunomide

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • Montréal, Quebec, Canada
      Department of Pathology
    Mar 23, 2021

    Multiple Sclerosis Trial in San Diego, Canada (Teriflunomide (HMR1726))

    Recruiting
    • Multiple Sclerosis
    • Teriflunomide (HMR1726)
    • San Diego, California
    • +1 more
    Jan 12, 2022

    Multiple Sclerosis Trial in Ramat Gan (COVID-19 vaccination)

    Recruiting
    • Multiple Sclerosis
    • COVID-19 vaccination
    • Ramat Gan, Israel
      Sheba Medical Center
    Oct 6, 2021

    Teriflunomide Observational Effectiveness Study

    Completed
    • Relapsing Remitting Multiple Sclerosis
    • Montréal, Quebec, Canada
      CHUM
    Aug 17, 2021

    Teriflunomide Tecfidera LMCE

    Completed
    • Tecfidera
    • Teriflunomide
    • Buffalo, New York
      Buffalo Neuroimaging Analysis Center
    Jan 4, 2021

    Teriflunomide Elimination, Healthy Volunteers Trial in Tampa (teriflunomide, Colestipol)

    Terminated
    Has Results
    • Teriflunomide Elimination
    • Healthy Volunteers
    • Tampa, Florida
      USF Carol and Frank Morsani Center for Advanced Healthcare
    Apr 1, 2020

    Relapsing Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo (match to Teriflunomide), Teriflunomide)

    Active, not recruiting
    • Relapsing Multiple Sclerosis
    • Cullman, Alabama
    • +275 more
    Nov 7, 2022

    Relapsing Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo (match to Teriflunomide), Teriflunomide)

    Active, not recruiting
    • Relapsing Multiple Sclerosis
    • Mobile, Alabama
    • +278 more
    Nov 7, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Early Highly Effective Therapies Group
    • Escalation Therapies Group
    • Aurora, Colorado
    • +30 more
    Jul 22, 2022

    d in the Treatment of Multiple Sclerosis

    Not yet recruiting
    • Multiple Sclerosis
    • Measurement of concentrations of orally-used DMDs
    • +3 more
    • Ostrava, Moravian-Silesian Region, Czechia
    • +1 more
    Dec 5, 2022

    Multiple Sclerosis Trial (Frexalimab, Teriflunomide, Placebo infusion)

    Not yet recruiting
    • Multiple Sclerosis
    • (no location specified)
    Nov 15, 2023

    HAM/TSP Trial run by the NINDS (Teriflunomide)

    Recruiting
    • HAM/TSP
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Multiple Sclerosis Trial in Chicago (Hematopoietic Stem Cell Therapy, Standard treatment with a conventional drug)

    Completed
    Has Results
    • Multiple Sclerosis
    • Hematopoietic Stem Cell Therapy
    • Standard treatment with a conventional drug
    • Chicago, Illinois
      Northwestern University, Feinberg School of Medicine
    Aug 10, 2020

    Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

    Recruiting
    • Atrial Fibrillation
    • Heart rhythm measurements with Preventicus®
    • +3 more
    • Genk, Limburg, Belgium
      Ziekenhuis Oost-Limburg
    Aug 28, 2023

    ECMO Braile Biomédica® in COVID-19 Patients

    Recruiting
    • COVID-19
    • Patients underwent cardiorespiratory support
    • Lago Sul, Brasília - DF, Brazil
      Hospital Brasília
    Oct 13, 2023

    Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

    Not yet recruiting
    • Metastatic Gastric Adenocarcinoma
    • +2 more
    • nal-IRI /Experimental
    • +2 more
    • (no location specified)
    Jun 25, 2023

    Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)

    Recruiting
    • Venous Leg Ulcer
    • Diabetic Foot
    • AQUACEL® Ag+ Extra™
    • Cutimed® Sorbact®
    • Barranquilla, Colombia
    • +13 more
    May 26, 2023

    Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)

    Recruiting
    • Dental Implants
    • Dynamic Computer Assisted Surgery
    • Freehand
    • L´hospitalet de Llobregat, Catalunya, Spain
      University of Barcelona
    Aug 31, 2023

    Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)

    Completed
    • Carpal Tunnel Syndrome
    • KForce Sens
    • Baseline Electrıgoniometer
    • Denizli, Turkey
      Pamukkale University
    Sep 14, 2023

    Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical

    Not yet recruiting
    • Tricuspid Regurgitation
    • Tricuspid Valve Disease
    • TricValve® Transcatheter Bicaval Valve System
    • Medical Therapy Arm
    • Cleveland, Ohio
    • +10 more
    Nov 14, 2023

    Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)

    Recruiting
    • Vaccine-Preventable Diseases
    • +2 more
    • Oral typhoid fever vaccine
    • Oral cholera vaccine
    • Helsinki, Finland
      Meilahti Vaccine Research Center, Helsinki University Hospital
    Oct 27, 2023